QT/QTc evaluation and comparison study by digital ECG recorder and Digital 12 lead Holter ECG recorder with Moxifloxacin single dose on healthy Japanese volunteers.

QT/QTc evaluation and comparison study by digital ECG recorder and Digital 12 lead Holter ECG recorder with Moxifloxacin single dose on healthy Japanese volunteers. - Moxifloxacin on QT intervals

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007489

Enrollment

Registered

2012-03-14

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

Moxifloxacin 400mg DHC(R) Mutivitamine (Vit B C D E P etc.)

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Those who satisfy following conditions on screening check-ups. Body weight more than 50 kg, BMI more than 17.6, less than 26.4. Healthy volunteers with the written informed consent.

Exclusion criteria

Exclusion criteria: On screening check-ups, QTc more than 450 msec. Heart rate less than 40, more than 100. Family history of Long QT Syndrome. History of syncope or loss of consciousness. Drugs or alcohol addiction.

Design outcomes

Primary

Measure	Time frame
Prove the similarity of QT/QTc data from different ECG recording methods.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026